The Centralized List annual renewal application and fee must be submitted to DOJ by January 31st of each year regardless of the date of initial placement on the Centralized List. The Centralized List portion of the annual fee is $20.00 per licensee at each dealership.
Hydrocodone Bitartrate, USP 7.5 mg. Ibuprofen, USP 200 mg. VICOPROFEN (hydrocodone and ibuprofen) is supplied in a fixed combination tablet form for oral administration. VICOPROFEN (hydrocodone and ibuprofen) combines the opioid analgesic agent, hydrocodone bitartrate, with the nonsteroidal anti-inflammatory (NSAID) agent, ibuprofen.
(2) All prescriptions for Schedule II, Schedule III, Schedule IV, and Schedule V controlled substances dispensed pursuant to this subdivision shall be reported by the dispensing pharmacy to the Department of Justice in the manner prescribed by subdivision (d) of Section 11165.